Intelicanna Ltd
INTL.TA
Tel Aviv Stock Exchange110.00
ILA
-0.20
- -
Intelicanna Ltd
INTL.TA
(Tel Aviv Stock Exchange)
Recent
price
110.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Intelicanna Ltd Intelicanna Ltd operates as a pharmaceutical company focused on medical cannabis in Israel. The company grows, cultivates, produces, researches, markets, and sells medical cannabis products, leveraging plant genetics, agro technologies, downstream processing, and product development to create high-quality offerings for medical and wellness purposes; it maintains a state-of-the-art Snow-White Medifarm Cultivation Facility for consistent local production and pursues international projects involving medical cannabis farms and products. Intelicanna targets the Israeli medical cannabis market and expands globally, serving healthcare providers and patients with cannabis-based therapies. Founded prior to its public listing on the Tel Aviv Stock Exchange (INTL.TA) and headquartered in Israel, the company benefits from proven Israeli expertise in cultivation and processing. In a major strategic shift, Ray TLV Real Estate Ltd completed the acquisition of Intelicanna Ltd for NIS 9.5 million through a reverse merger transaction in December 2023, marking significant ownership and operational changes. Recent developments include partnerships such as agreements with Citrine Global for business development and consulting services, as well as the addition of Aviv Geffen as a marketing and branding consultant; the company also pays semi-annual dividends with a current yield reflecting its financial strategy amid challenging returns like a reported ROA of -921.4% as of late 2025.